GridION Mk1 CapEX with starter pack and Rapid PCR barcoding and Shipping Direct to Cambodia
ID: RFQ-NIAID-24-2209041Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)
Timeline
    Description

    The Department of Health and Human Services, National Institutes of Health, is seeking to procure a GridION Mk1 CapEX with starter pack and Rapid PCR barcoding for shipping direct to Cambodia. The GridION sequencing instrument and supplies, manufactured by Oxford Nanopore Technologies in the United Kingdom, are intended for use in the International Center of Excellence (ICER) Cambodia. ICER Cambodia requires long-read sequencing to provide full or near-full genomes of pathogens for structural genomics and pathogen evolutionary analyses. The GridION Mk1 sequencing platform is particularly suitable for this purpose, as it provides high-throughput data generation and real-time processing and analysis of data. The procurement of the GridION Mk1 sequencer will facilitate training and support efforts for public health initiatives in Cambodia. The government intends to award a firm fixed price purchase order based on technical capability and price. Offers must be submitted by March 9, 2024, and any questions or concerns should be directed to Diana Rohlman at diana.rohlman@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    Lifecycle
    Title
    Type
    Similar Opportunities
    Maintenance: MiSeq and NovaSeq 6000 Sequencers
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), is seeking to procure a one-year maintenance contract for its Illumina NovaSeq 6000 and MiSeq DNA sequencers. The contract will cover a Silver Support Plan, which includes full repair parts, labor, travel, and remote technical support, ensuring the continuous operation of these critical sequencing machines essential for high-throughput and accurate DNA analysis. Interested vendors must submit their quotations by January 27, 2025, at 12:00 PM EST, to Tina Robinson at robinsti@mail.nih.gov, and must be registered in the System for Award Management (SAM) to be eligible for award consideration.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    Preventative Maintenance 10x Genomics Chromium iX/X
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract to 10x Genomics, Inc. for preventative maintenance of the Chromium X single cell capture system, which is critical for ongoing research in neural regeneration. The contract aims to ensure the operability of the equipment, minimize downtime, and support the generation of sequencing libraries necessary for the Molecular Neurobiology Section's research efforts. This maintenance service is essential for maintaining the functionality of the proprietary equipment, which requires OEM-certified technicians and compatible parts, as no alternative suppliers are available. Interested parties can contact Frederick Weddington at frederick.weddington@nih.gov or by phone at 301-594-6835, with the response date for proposals set for January 17, 2025, and the performance period expected to run from January 27, 2025, to January 26, 2030.
    Brand name or equal, Reagent needed for amplification of DNA for next generation sequencing in high-throughput assay for chromatin for The National Center for Advancing Translational Sciences (NCATS)
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is seeking suppliers for a brand name or equal reagent necessary for the amplification of DNA for next-generation sequencing in high-throughput assays for chromatin, specifically for the National Center for Advancing Translational Sciences (NCATS). The procurement aims to acquire the NEBNext Ultra II Q5 Master Mix in a bulk order of 500 mL, which is critical for optimizing protocols and facilitating high-throughput screening. This reagent is essential for advancing medical research and enhancing the development of diagnostics and therapeutics across various human diseases. Interested vendors must submit their capability statements and relevant documentation by January 22, 2025, at 9 am Eastern Time to Giuliana Faller at giuliana.faller@nih.gov.
    Brand-Name or Equal, Acquisition of Agilent Bioanalyzer 5200 Fragment analyzer system for ETB Group at NCATS.
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking responses for the acquisition of a Brand-Name or Equal Agilent Bioanalyzer 5200 Fragment Analyzer system for the ETB Group at the National Center for Advancing Translational Sciences (NCATS). The procurement includes the Bioanalyzer system, a computer and monitor, controller and analysis software, capillary array, and installation/familiarization services, which are crucial for nucleic acid quantification and characterization in biomedical research. This advanced equipment is essential for high-throughput separation and quantification of DNA and RNA, supporting NIH's mission to enhance health and reduce illness through innovative medical research. Interested vendors must submit their capability statements by January 27, 2025, at 9 am Eastern Time, to Contract Specialist Giuliana Faller at giuliana.faller@nih.gov.
    Nova Benchtop System
    Dept Of Defense
    The Department of Defense, through the United States Army Medical Research Acquisition Activity (USAMRAA), intends to negotiate a sole source contract with Helix Biotech for the acquisition of a Nova Benchtop Microfluidics device. This procurement aims to secure a chip-less, scalable, and highly flexible modular system essential for the encapsulation of mRNA for cellular delivery, including all necessary ancillary components, delivery, self-installation with virtual support, training, and a one-year manufacturer warranty. The device is critical for producing lipid nanoparticles, which play a significant role in various biomedical applications. Interested parties may submit their capability information by 2:00 p.m. Eastern Time on January 16, 2025, to Ms. Natalie Bethel at natalie.l.bethel2.civ@health.mil, as this notice is not a request for competitive quotations.
    Chemistry Analyzer Piccolo Xpress, CLIA Waived (AMBIS 2247161)
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of two Piccolo Xpress Chemistry Analyzers as part of a combined synopsis/solicitation. These analyzers are essential for the Vaccine Research Center's ongoing clinical trials in Kenya, requiring compatibility with existing laboratory equipment to ensure data consistency and continuity in research. The Piccolo Xpress is a portable, fully automated clinical chemistry analyzer capable of performing over 30 blood chemistry tests, providing rapid results with minimal user interaction. Interested vendors must submit their quotes by January 17, 2025, at 4:00 PM EST, and can direct inquiries to Rita Davis at rita.davis@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.
    NUcleic acid Linked Immuno-Sandwich Assay Reagents
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of NUcleic acid Linked Immuno-Sandwich Assay Reagents, aimed at enhancing biomarker discovery for neurodegenerative disease research at the Center for Alzheimer’s Disease and Related Dementias (CARD). The acquisition includes the Alamar NULISAseq Inflammation Panel, with a requirement for 30 units that must demonstrate high sensitivity in analyzing over 250 proteins from minimal sample volumes, ensuring compatibility with the ARGO proteomics platform. This procurement is critical for advancing research capabilities in the detection of biomarkers related to Alzheimer’s Disease and Related Dementias (ADRD). Interested vendors must submit their quotations by January 22, 2025, at 12:00 PM Eastern Time, to Andrea Clay at amcgee@nida.nih.gov, and must comply with all specified federal regulations and provisions outlined in the solicitation.
    Acquisition of SomaScan 7K and 11K Assay Kits
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure fifty-nine (59) SomaScan 7K and/or 11K Assay Kits on a sole source basis from SomaLogic Operating Co., Inc. This acquisition is intended to support the Center for Human Immunology, Inflammation, and Autoimmunity (CHI) in their systems biology research, which involves measuring a wide range of proteins in various human biological samples to enhance understanding of the immune system and related diseases. The procurement aligns with federal initiatives to advance health science research capabilities, with an estimated delivery date for the products set for December 20, 2024, and a performance period from February 21, 2025, to February 20, 2026. Interested vendors may contact Kathy Song at kathy.song@nih.gov for further information and must submit their capabilities statements within 15 days of this notice.
    Assay Kits for Lumipulse instrument
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of assay kits for the Lumipulse instrument, aimed at quantifying specific biomarkers related to Alzheimer's Disease. The acquisition includes a total of 4,410 assays for measuring abeta42, abeta40, and pTau 217, which will support ongoing research into cognitive decline and neurodegeneration using samples from the Baltimore Longitudinal Study of Aging. Interested vendors must submit their quotations by 5:00 p.m. Eastern Time on January 15, 2025, and can direct inquiries to Iris Merscher at iris.merscher@nih.gov or by phone at 301-827-2547. This procurement is conducted under simplified acquisition procedures and is open to all qualified offerors without set-aside restrictions.